VISION GLOBAL HOLDINGS LTD has a total of 69 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, Singapore and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are ENDOCYTE INC, INNOVATE BIOPHARMACEUTICALS INC and IO BIOTECH APS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Singapore | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | African Regional Industrial Property Organization | 4 | |
#5 | China | 4 | |
#6 | Hong Kong | 4 | |
#7 | Australia | 3 | |
#8 | Canada | 3 | |
#9 | Chile | 3 | |
#10 | EPO (European Patent Office) | 3 | |
#11 | Israel | 3 | |
#12 | Republic of Korea | 3 | |
#13 | Morocco | 3 | |
#14 | Mexico | 3 | |
#15 | Philippines | 3 | |
#16 | Taiwan | 3 | |
#17 | Brazil | 2 | |
#18 | EAPO (Eurasian Patent Organization) | 2 | |
#19 | Uruguay | 2 | |
#20 | Argentina | 1 | |
#21 | New Zealand | 1 | |
#22 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Foods and drinks | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Electrotherapy | |
#5 | Microorganisms | |
#6 | Measuring microorganism processes | |
#7 | Enzymes | |
#8 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Kwok Sui Yi | 57 |
#2 | Wai Norman Fung Man | 56 |
#3 | Wong Bing Lou | 51 |
#4 | Leung Yun Chung | 20 |
#5 | Lau Sze Hang | 18 |
#6 | Wong Man Kin | 17 |
#7 | Man Cornelia Wing Yin | 13 |
#8 | Norman Fung Man Wai | 4 |
#9 | Man Comelia Wing Yin | 4 |
#10 | Bing Lou Wong | 4 |
Publication | Filing date | Title |
---|---|---|
US2020361988A1 | Mertansine polypeptide conjugates | |
WO2019219002A1 | Method for n-terminal functionalization of polypeptides and products thereof | |
US2019054173A1 | Compositions for photodynamic therapy and fluorescence diagnosis of cancers and other diseases | |
NZ731411A | Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging | |
AU2014265659A1 | Pharmaceutical composition comprising modified hemoglobin- based therapeutic agent for cancer targeting treatment and diagnostic imaging | |
AP201508848A0 | Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging | |
US2014255377A1 | Albumin-binding arginine deminase and the use thereof |